PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas
Soft-tissue sarcomas (STS) are a group of rare, heterogeneous, and aggressive tumors, with high metastatic risk and relatively few efficient systemic therapies.In the quest for new treatments, the immune system Course a pied - Femme - Sous-vetements - Brief represents an attractive therapeutic target.Recently, PD1/PDL1 inhibitors showed very promis